300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Consumer
Mobile
Enterprise Software
Local
Platforms
Health Care
Travel
InsurTech
Retail
Oil and Gas
Film
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Ireland
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bangladesh
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Hungary
Finland
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Hillhouse Investment, VC Fund

Hillhouse Investment

VC Fund

Changyang, China

Hillhouse Investment is a VC fund in Changyang focused on Biotechnology and Health Care. Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Total investments:
331
Last investment:
Lead investor:
38%
Fund size:
$11B
Last fund:

Last updated:

Industries Hillhouse Investment invests in

BiotechnologyHealth CareSoftwareMedicalManufacturing

Stages Hillhouse Investment invests in

Series BSeries ASeries CSeedSeries D

Countries Hillhouse Investment invests in

ChinaUnited StatesSingaporeIndiaHong Kong

Round sizes

Series A $2.9M–$165MSeries B $15M–$230MSeries C $15M–$220M

Contacts

NameEmailPhoneSocials
See all 10 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$2.9M–$165M
Series B
$15M–$230M
Series C
$15M–$220M

Investment Focus

Industry

  • Biotechnology 56 (17%)
  • Health Care 46 (14%)
  • Software 40 (12%)
  • Medical 35 (11%)
  • Manufacturing 35 (11%)
See all 222 industries →

Stage

  • Series B 83 (25%)
  • Series A 73 (22%)
  • Series C 46 (14%)
  • Seed 30 (9%)
  • Series D 22 (7%)
See all 14 stages →

Country

  • China 210 (63%)
  • United States 24 (7%)
  • Singapore 7 (2%)
  • India 5 (2%)
  • Hong Kong 5 (2%)
See all 18 countries →

Team

NameTitleInvestmentsLinksEmail
Zhang Lei
Zhang Lei Chairman, Founder, CEO
Chairman, Founder, CEO Total investments: 4
Find email
David Rhee Partner
Partner Total investments: 16
Find email
Ed Zhang
Ed Zhang Venture Partner, HH Bioventure
Venture Partner, HH Bioventure Total investments: 0
Find email
Huang Liming Partner
Partner Total investments: 9
Find email
Li Qiang Operating GM
Operating GM Total investments: 6
Find email
See all 10 team members →

Investments

CompanyDescriptionRoundLinks
Vita Dynamics
Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. $13.8M / Seed / Mar 21, 2025
Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics Angel / Mar 12, 2025
Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs $54.9M / Series B / Feb 27, 2025
ZJeagles Comsemi is the designer and producer of optical communication chips designed for data centers and other industrial applications. $41.4M / Series B / Jan 24, 2025
Vita Dynamics
Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. $13.8M / Seed / Jan 22, 2025
Dinii is a mobile order platform for take-out shops. $51.5M / Series B / Sep 25, 2024
Ascentium emphasizes innovation, support, and strategic guidance and it focus on enabling success and prosperity. Seed / Sep 24, 2024
Xingmai Innovation Xingmai Innovation
Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots. Series A / Sep 19, 2024
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Its drug development engine delivers superior biologics optimized to create T-cell engagement by leveraging two technologies that power a pipeline of high-value therapeutics – a solid tumor synergy platform and an I&I platformthat offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. $165M / Series A / Jul 23, 2024
Xiaohongshu is a lifestyle-sharing platform for users to share positive energy and good life through the sharing of text, pictures, and videos. Xiaohongshu offers an overseas shopping tip app. Xiaohongshu started its business by helping overseas travelers to draft a shopping list before they hit the roads. But with the aggregation of more UGCcontent, the service is transforming into a community for those who are passionate about fashion and shopping and want to know more about these fields even though they do not have overseas traveling plans on their schedules. Secondary Market / Jul 11, 2024
See all 331 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Consumer
Mobile
Enterprise Software
Local
Platforms
Health Care
Travel
InsurTech
Retail
Oil and Gas
Film
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Ireland
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bangladesh
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Hungary
Finland
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Hillhouse Investment invest in?

Hillhouse Investment invests primarily in Biotechnology, Health Care and Software startups, most often at Series B and Series A stage. Most of the 331 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Hillhouse Investment's check size?

Hillhouse Investment typically joins rounds of $2.9M–$165M at Series A, $15M–$230M at Series B and $15M–$220M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hillhouse Investment participates in.

How do I contact Hillhouse Investment?

Public channels for Hillhouse Investment include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Hillhouse Investment?

The team at Hillhouse Investment includes Zhang Lei (Chairman, Founder, CEO), David Rhee (Partner) and Ed Zhang (Venture Partner, HH Bioventure), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Hillhouse Investment Hillhouse Investment Find emails